Advanced Infusion Therapy for Chronic Gout
For some patients, first-line oral therapies are not enough to control their disease. That is when timely specialty evaluation and coordinated access to advanced therapy can make a real difference.
Inspire Health IV helps coordinate the clinical, administrative, and infusion support needed to help eligible patients move forward with treatment.
KRYSTEXXA®
When chronic gout remains uncontrolled, advanced treatment may be an option.
KRYSTEXXA® (pegloticase) is an FDA-approved infusion therapy for adults with chronic gout refractory to conventional treatment—meaning their gout remains uncontrolled despite, or because they cannot tolerate, standard urate-lowering therapies.
Appropriate patients may have recurrent flares, tophi, persistent elevated uric acid, or joint damage. Because treatment requires clinical evaluation, screening, payer approval, and coordinated infusion support, the path can feel overwhelming.
Inspire Health IV helps coordinate those details so eligible patients can move forward with clarity and confidence.
We Help Coordinate the Process
Benefits verification and prior authorizations
Billing and manufacturer-support enrollment
Specialty evaluation and referral coordination
White-glove patient scheduling and communication
Infusion operations and ongoing treatment updates